Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Mazindol

EU orphan designation number: EU/3/15/1444   
Active ingredient: Mazindol
Indication: Treatment of narcolepsy
Sponsor: HAC Pharma
Péricentre IV, 8 avenue de la Côte de Nâcre, 1400 Caen, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/02/2015 Orphan designation EMA/OD/254/14 (2015)942 of 12/02/2015